Pentagon funds vaccine to counter airborne exposure to Ebola

53

DoD considers Ebola spreading through air a severe threat

By Kit Daniels | Infowars.com

Citing concerns over “aerosol exposure to Ebola,” the Pentagon awarded a $9.5 million contract to a biotechnology company to manufacture an Ebola vaccine.

The company, Profectus BioSciences, announced today that the Pentagon “contracted the manufacture and … preclinical testing of the Profectus trivalent Ebola/Marburg vaccine” which had previously been tested to “confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

“In July 2014, Profectus BioSciences and the GNL were awarded a 3 year, $8.5M grant from the DOD/Joint Vaccine Acquisition Program to support development of a lyophilized trivalent VesiculoVax™-vectored vaccine to protect against all major strains of Ebola and Marburg viruses delivered as aerosols,” the press release stated. “The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

Read Full Article

The Shepard Ambellas Show airs LIVE weekdays (Mon-Fri) on the Shepard Ambellas YouTube channel from 5-7 pm Eastern/4C/2P. Subscribe now! Turn notifications on immediately. The show is nationally syndicated on iHeartRadio. An archived version of the show is also available on Apple Podcasts, Spotify, Google Podcasts, Castbox, Deezer, Podcast Addict, Podchaser, JioSaavn, and Spreaker for your listening pleasure.